UiO-based platforms in biomedicine: Advanced nanovehicles for effective treatment
Ren Zhang,
No information about this author
Abdulnasser Mahmoud Karami,
No information about this author
Qianying Huang
No information about this author
et al.
Materials Today Chemistry,
Journal Year:
2025,
Volume and Issue:
45, P. 102645 - 102645
Published: March 22, 2025
Language: Английский
Causal relationship between sarcopenia with osteoarthritis and the mediating role of obesity: a univariate, multivariate, two-step Mendelian randomization study
Zicheng Jin,
No information about this author
Rui Wang,
No information about this author
Linzi Jin
No information about this author
et al.
BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: May 29, 2024
Abstract
Background
Recent
genetic
evidence
supports
a
causal
role
for
sarcopenia
in
osteoarthritis,
which
may
be
mediated
by
the
occurrence
of
obesity
or
changes
circulating
inflammatory
protein
levels.
Here,
we
leveraged
publicly
available
genome-wide
association
study
data
to
investigate
intrinsic
relationship
between
sarcopenia,
obesity,
levels,
and
osteoarthritis.
Methods
In
this
study,
used
Mendelian
randomization
analyses
explore
phenotypes
(Appendicular
lean
mass
[ALM],
Low
hand-grip
strength
[LHG],
usual
walking
pace
[UWP])
osteoarthritis
(Knee
[KOA],
Hip
[HOA]).
Univariable
(UVMR)
were
performed
using
inverse
variance
weighted
(IVW)
method,
MR-Egger,
median
simple
mode,
with
IVW
method
being
primary
analytical
technique.
Subsequently,
independent
effects
phenotype
on
investigated
multivariate
(MVMR)
analysis.
To
further
mechanisms
involved,
proteins
introduced
as
mediator
variables,
two-step
analysis
was
mediating
ALM
KOA
well
proportions.
Results
UVMR
showed
ALM,
LHG,
UWP
[(OR
=
1.151,
95%
CI:
1.087–1.218,
P
1.19
×
10
–6
,
FDR
7.14
)
(OR
1.215,
1.004–1.470;
0.046,
0.055)
0.503,
0.292–0.867;
0.013,
0.027)],
HOA
1.181,
1.103–1.265,
2.05
6.15
0.438,
0.226–0.849,
0.014,
0.022)].
MVMR
adjusting
confounders
(body
index,
insomnia,
sedentary
behavior,
bone
density),
relationships
observed
[(ALM:
OR
1.323,
95%CI:
1.224-
1.431,
2.07
–12
),
(LHG:
1.161,
1.044-
1.292,
0.006),
(UWP:
0.511,
0.290-
0.899,
0.020)],
(ALM:
1.245,
1.149-
1.348,
7.65
–8
).
MR
analysis,
identified
play
potential
(proportion
mediated:
5.9%).
Conclusions
The
results
suggest
that
decreased
appendicular
mass,
grip
strength,
speed
increase
risk
increases
patients
European
population.
Obesity
plays
due
body
reduction.
Language: Английский
Phospholipase D2: A biomarker for stratifying disease severity in acute pancreatitis?
Zhi‐Hui Wang,
No information about this author
Jia-Hui Lv,
No information about this author
Yun Teng
No information about this author
et al.
World Journal of Gastroenterology,
Journal Year:
2025,
Volume and Issue:
31(11)
Published: March 12, 2025
In
this
editorial,
we
critically
evaluate
the
recent
article
by
Niu
et
al
,
which
explores
potential
of
phospholipase
D2
(PLD2)
as
a
biomarker
for
stratifying
disease
severity
in
acute
pancreatitis
(AP).
AP
is
clinically
heterogeneous
inflammatory
condition
that
requires
reliable
biomarkers
early
and
accurate
classification
severity.
PLD2,
an
essential
regulator
neutrophil
migration
responses,
has
emerged
promising
candidate.
Although
current
such
C-reactive
protein
procalcitonin
provide
general
indications
inflammation,
they
lack
specificity
regarding
molecular
mechanisms
underlying
progression.
Recent
studies,
including
research
conducted
suggest
inverse
correlation
between
PLD2
expression
severity,
offering
both
diagnostic
insights
mechanistic
understanding.
This
editorial
evaluates
role
broader
context
research.
Evidence
indicates
decreased
levels
are
associated
with
increased
chemotaxis
cytokine
release,
contributing
to
pancreatic
systemic
inflammation.
However,
several
challenges
remain,
need
large-scale
validation
functional
studies
establish
causation,
standardization
measurement
protocols.
Additionally,
further
investigation
into
temporal
dynamics
its
variability
across
diverse
populations
warranted.
Looking
ahead,
holds
revolutionize
management
integrating
diagnostics
precision
medicine.
The
utilization
multi-omics
approaches
advancements
platforms
could
position
fundamental
diagnosis,
prognosis,
potentially
therapeutic
targeting.
While
promising,
it
crucial
conduct
critical
evaluations
rigorous
validations
PLD2’s
ensure
efficacy
improving
patient
outcomes.
Language: Английский
Glabridin Suppresses Macrophage Activation by Lipoteichoic Acid In Vitro: The Crucial Role of MAPKs-IL-1β-iNOS Axis Signals in Peritoneal and Alveolar Macrophages
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 174 - 174
Published: Jan. 24, 2025
Inflammation,
a
fundamental
response
to
infection
and
injury,
involves
interactions
among
immune
cells
signaling
molecules.
Dysregulated
inflammation
contributes
diseases
such
as
autoimmune
disorders
cancer.
Interleukin-1
beta
(IL-1β),
produced
by
macrophages
in
lipoteichoic
acid
(LTA)
from
Gram-positive
bacteria,
is
key
inflammatory
mediator.
Glabridin
(GBD),
bioactive
compound
licorice
root,
exhibits
anti-inflammatory
properties.
This
study
investigates
GBD’s
effects
on
LTA-induced
proinflammatory
RAW
264.7
murine
alveolar
macrophages,
MH-S,
focusing
IL-1β
expression
pathways.
Cell
viability
assays
confirmed
that
20
μM
GBD
was
non-cytotoxic.
Confocal
microscopy
quantitative
PCR
showed
significantly
reduced
fluorescence
intensity,
mRNA,
protein
levels.
also
inhibited
inducible
nitric
oxide
synthase
(iNOS)
(NO)
production.
Further
analysis
revealed
suppressed
NF-κB
p65
nuclear
translocation
selectively
modulated
MAPK
pathway
activation
reducing
JNK
p38
phosphorylation
without
affecting
ERK.
Studies
using
specific
inhibitors
demonstrated
production
reduction
mechanistically
linked
inhibition.
These
findings
highlight
potential
therapeutic
agent
for
through
its
ability
modulate
critical
mediators
Language: Английский
Identification of the Cellular Tipping Point in the Inflammation Model of LPS-Induced RAW264.7 Macrophages Through Raman Spectroscopy and the Dynamical Network Biomarker Theory
Molecules,
Journal Year:
2025,
Volume and Issue:
30(4), P. 920 - 920
Published: Feb. 17, 2025
Raman
spectroscopy
is
a
non-destructive
spectroscopic
technique
that
provides
complex
molecular
information.
It
used
to
examine
the
physiological
and
pathological
responses
of
living
cells,
such
as
differentiation,
malignancy,
inflammation.
The
two
cellular
states,
initial
full-blown
inflammation,
have
mainly
been
investigated
using
comparative
analysis
with
spectra.
However,
tipping
point
inflammatory
state
transition
remains
unclear.
Therefore,
present
study
attempted
identify
inflammation
cell
model.
We
stimulated
RAW264.7
mouse
macrophages
lipopolysaccharide
(LPS)
continuously
collected
spectra
every
2
h
for
24
from
states.
A
Partial
Least
Squares
Principal
Component
Analysis-Linear
Discriminant
Analysis
predicted
14
after
LPS
stimulation.
In
addition,
Dynamical
Network
Biomarker
(DNB)
analysis,
identifying
in
various
phenomena,
indicated
was
identified
tryptophan
biomarker.
results
multivariate
DNB
show
point.
Language: Английский
Advances in plant-derived vesicle like nanoparticles-based therapies for inflammatory diseases
Asian Journal of Pharmaceutical Sciences,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101052 - 101052
Published: April 1, 2025
Language: Английский
PathwayMind: An Innovative Tool and Database for Pathway Perturbation Analysis, Uncovering Critical Pathways for Drugs and Target Protein Sets
Computational Biology and Chemistry,
Journal Year:
2025,
Volume and Issue:
118, P. 108466 - 108466
Published: April 15, 2025
Language: Английский
The Journey of p38 MAP Kinase Inhibitors: From Bench to Bedside in Treating Inflammatory Diseases
Fuwei Yang,
No information about this author
Zhao Lijie,
No information about this author
Q. Alan Xu
No information about this author
et al.
European Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
280, P. 116950 - 116950
Published: Oct. 11, 2024
Language: Английский
Advances in the Diagnosis and Management of Inflammatory Bowel Disease (IBD)
Advanced Research in Gastroenterology & Hepatology,
Journal Year:
2024,
Volume and Issue:
20(4)
Published: July 5, 2024
journal
of
clinical
gastroenterology
is
part
the
Juniper
publishers
which
devoted
to
publish
subject-specific
articles
focused
on
needs
individual
research
communities
across
all
areas
biology
and
medicine.
Language: Английский